Collaboration

Handshake
#Collaboration #Drug development #Immunology / Virology & Vaccines #mRNA

BioNet and BIA Separations collaborate to develop mRNA vaccines 

BioNet and BIA Separations, now part of Sartorius, have developed an optimised mRNA manufacturing process.   BIA’s expertise in chromatographic columns for mRNA purification combined with BioNet’s expertise in the product development of genetic vaccines have, since early 2021, enabled both teams to collaborate on the optimisation and upscale of a high-yield… Read More

#News

#Antivirals #Biologics #Biopharmaceuticals #Collaboration #Covid-19 #Laboratory data

This week in drug discovery (1-5 November) 

News round-up by DDW’s Megan Thomas for 1-5 November DDW’s Megan Thomas has selected five stories which showcase the international scope of the drug discovery industry in terms of research, innovation, collaboration and development. 1. New consortium to boost Covid-19 vaccine production in South Africa The Medicines Patent… Read More

#News #Trending News

#Collaboration #Drug discovery

This week in drug discovery (25-29 October)  

News round-up by DDW’s Megan Thomas for 25-29 October   DDW’s Megan Thomas has selected five stories which highlight the results that can be achieved through collaboration in the drug discovery sector.    1. Australian researchers identify new pathways to target breast cancer  A… Read More

#News #Trending News

#Collaboration #Drug candidates #Drug development #Drug discovery

Call for application: AI for antibody design 

German independent research institute BioMed X has announced the launch of a global call for application to identify biomedical scientists and inventors to form a new startup at AION Labs’, Israel. The company spearheads the adoption of AI technologies and computational science to solve therapeutic challenges.  The chosen AION Labs startup… Read More

#News

#Collaboration #Drug development

Ferrer and Treeway collaborate to develop treatment for ALS

Ferrer and Treeway have entered into a licence agreement for the development and commercialisation of an oral formulation of edaravone (TW001/FNP122) for Amyotrophic Lateral Sclerosis (ALS) in certain territories, including Europe and some Asian countries.   Ferrer is responsible for advancing the development and commercialisation of the product and will make royalty payments to Treeway at certain milestones. The deal… Read More

#News

#Collaboration #Drug discovery #Funding #Research

This week in drug discovery (18-22 October) 

News round-up by DDW’s Megan Thomas for 18-22 October  DDW’s Megan Thomas has selected five stories which highlight the opportunities in the drug discovery sector.   1. Researchers receive $4 million for exceptional junior scientists  Two Mount Sinai cancer researchers will receive $4… Read More

#News

#Collaboration #Digital focus #Life sciences #Public health

Pistoia Alliance responds to the needs of the life science industry 

The Pistoia Alliance has announced plans to respond to the changing needs of the life science industry as digital transformation accelerates.  The Alliance has hired Imran Haq, Anca Ciobanu and Linda Kasim to lead the three new themes of its reorganised project portfolio: Emerging Science and Technology,… Read More

#News

#Antigen #Biotechnology #Collaboration

Collaboration: discovery against GPCRs, ion channels and transporters 

Swedish biotech company Salipro Biotech has entered into a collaboration and licensing agreement with AbCellera for access to its proprietary Salipro Platform, which stabilises challenging G protein coupled receptor (GPCR), ion channel and transporter antigens.  “We are excited to build on the success of our previous studies and deepen our relationship with the team at AbCellera,”… Read More

#News

#Collaboration #Drug development #Drug discovery #Research

This week in drug discovery (11-15 October) 

News round-up by DDW’s Megan Thomas for 11-15 October   For this week’s drug discovery round up, DDW’s Megan Thomas has selected five stories that showcase how organisations and collaboration within the drug discovery industry can provide researchers and drug developers with the tools they need to move forward with… Read More

#News

#Collaboration #iPSC #Neuroscience

Neuroscience collaboration expands to include novel cell type 

Evotec has expanded its collaboration with Bristol Myers Squibb to include a new cell type.  The collaboration was initiated in December 2016 with the goal of identifying disease-modifying treatments for a broad range of neurodegenerative diseases. Currently approved drugs only offer short-term management of the patients’… Read More

#News

#Biomedical research #Biomedicine #Cell culture #Collaboration #Software

Collaboration offers high throughput 3D cell screening solution 

UPM Biomedicals has entered into an agreement with PerkinElmer to act as a distributor of the UPM GrowDex and GrowDase range of products. This new collaboration will offer researchers a complete solution for high throughput screening (HTS) of 3D cell cultures in early drug discovery, combining PerkinElmer’s cell imaging and automation solutions and… Read More

#News

#Biologics / Biotechnology #Cell painting #Collaboration #Drug discovery #Phenomics #Podcast

Recipe for success: collaboration in drug discovery – podcast 

The latest free-to-listen DDW podcast episode is titled “Recipe for success: collaboration in drug discovery”. It covers three articles written for Volume 22, Issue 2 – Spring 2021 of the Drug Discovery World Magazine, narrated by DDW’s Megan Thomas.  These articles are titled: “Why collaboration matters and… Read More

#Editor's Choice #News

#Biotechnology #Collaboration #Data #Technology #Webinar

Webinar reveals how to accelerate your drug discovery program 

This free-to-watch webinar, brought to you by Certara, reviews best practices for using technology to overcome challenges in order to accelerate discovery programs.  Drug discovery research requires understanding complex chemical, biological, logistical, and computational data from a variety of data sources. A key challenge for discovery scientists is efficiently… Read More

#Intelligence #News #Trends & Analysis

#Antibiotics #Antimicrobials #Collaboration

AMR Action Fund appointment will help with antibiotic development 

 The AMR Action Fund, a public-private partnership supporting the development of new antibiotics to address rising antimicrobial resistance (AMR), has appointed William (Bill) Burns as Board Chair.   Burns has worked in the pharmaceutical and life sciences industry throughout his life, providing invaluable experience for his role as… Read More

#News

#Blood cancer #Cancer research #Collaboration #Oncology

New cancer ‘inhibitor’ could lead to improved treatment options

Researchers have discovered a potential advancement in the treatment of chronic myeloid leukaemia (CML), which they hope will one day offer an improved option for treating patients with this form of blood cancer. The study– published in Science Translational Medicine and led by the University of Glasgow in collaboration with… Read More

#Cancer Research #Editor's Choice #News #Trending News

#Collaboration #Drug development #Drug discovery #Life sciences

Brooks introduces Azenta Life Sciences to advance sample solutions 

Brooks Life Sciences Services and Products businesses will be rebranded under the creation of a new identity – Azenta Life Sciences. Azenta will bring together Brookes’ existing portfolio of life sciences products and services to deliver integrated enterprise-wide sample exploration and management solutions.  “We are excited to announce the creation of Azenta as… Read More

#News